| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
2seventy bio (NASDAQ:TSVT) will release its quarterly earnings report on Tuesday, 2024-11-12. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate 2seventy bio to report an earnings per share (EPS) of $-0.30.
Anticipation surrounds 2seventy bio's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
During the last quarter, the company reported an EPS beat by $0.36, leading to a 4.83% increase in the share price on the subsequent day.
Here's a look at 2seventy bio's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.65 | -0.81 | -0.99 | -0.97 |
| EPS Actual | -0.29 | -0.81 | -1.11 | -1 |
| Price Change % | 5.0% | -1.0% | -2.0% | 2.0% |
Shares of 2seventy bio were trading at $4.73 as of November 07. Over the last 52-week period, shares are up 107.46%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for 2seventy bio visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: TSVT
